Consolidated Statement Of Income

Solasia Pharma K.K. - Filing #7272454

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Consolidated statement of income
Statement of income
Net sales
316,000,000 JPY
617,000,000 JPY
Cost of sales
131,000,000 JPY
280,000,000 JPY
Operating expenses
Selling, general and administrative expenses
1,026,000,000 JPY
1,025,000,000 JPY
Personnel expenses
350,000,000 JPY
391,000,000 JPY
Other
156,000,000 JPY
125,000,000 JPY
Operating expenses
Operating profit (loss)
-840,000,000 JPY
-688,000,000 JPY
Gross profit (loss)
185,000,000 JPY
337,000,000 JPY
Ordinary profit (loss)
-869,000,000 JPY
-678,000,000 JPY
Net sales
Operating expenses
Research and development expenses
113,000,000 JPY
136,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Non-operating income
Interest income
0 JPY
0 JPY
Other
JPY
0 JPY
Non-operating income
0 JPY
10,000,000 JPY
Non-operating expenses
Interest expenses
0 JPY
0 JPY
Other
0 JPY
JPY
Non-operating expenses
28,000,000 JPY
1,000,000 JPY
Share issuance costs
14,000,000 JPY
1,000,000 JPY
Gross profit
Profit (loss) before income taxes
-869,000,000 JPY
-678,000,000 JPY
Income taxes - current
0 JPY
0 JPY
Profit (loss)
-868,000,000 JPY
JPY
-868,000,000 JPY
JPY
JPY
-868,000,000 JPY
JPY
-679,000,000 JPY
JPY
JPY
-679,000,000 JPY
JPY
-679,000,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.